ArticleCancersPublished
A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Cancers
- Published
- Topic
- Clinical care
- Subject terms
- Ablation; prostate cancer; Clinical Trial; Focal Therapy; Irreversible Electroporation
- PubMed ID
- 38927884
- PubMed Central ID
- PMC11201469
- Open access
- Yes, open
- Added to directory
- Source checked